Hofseth BioCare ASA
HOFBFOTCHealthcare● Active
$0.17
+$0.00(+0.00%)
Market Cap$65819620
P/E Ratio—
52W High$0.176
52W Low$0.155
Hofseth BioCare ASA (HOFBF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HOFBF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: May 9, 2025EPS Actual
-$0.01
Revenue
$0.01B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
May 9, 2025
After Market Close
HOFBF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2025 | May 9, 2025 | — | -$0.01 | — | $0.01B | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.01 | — | $0.01B | — | — |
| — Q3 FY2024 | Sep 30, 2024 | — | -$0.01 | — | $0.01B | — | — |
| — Q2 FY2024 | Jun 29, 2024 | — | -$0.00 | — | $0.01B | — | — |
| — Q2 FY2024 | May 10, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2024 | Jan 4, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2023 | Sep 30, 2023 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.00 | — | $0.00B | — | — |
Q2 FY2025
May 9, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2024
Sep 30, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2024
Jun 29, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2024
May 10, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Jan 4, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Sep 30, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for HOFBF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | May 9, 2025 | — | $0.16 | $0.16 | +0.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.10 | $0.10 | +0.00% |
| — Q3 FY2024 | Sep 30, 2024 | — | $0.18 | $0.18 | +0.00% |
| — Q2 FY2024 | Jun 29, 2024 | — | $0.18 | $0.18 | +0.00% |
| — Q2 FY2024 | May 10, 2024 | — | $0.17 | $0.20 | +19.65% |
| — Q1 FY2024 | Jan 4, 2024 | — | No price data | $0.17 | — |
| — Q3 FY2023 | Sep 30, 2023 | — | No price data | $0.17 | — |
| — Q2 FY2023 | Jun 30, 2023 | — | No price data | $0.17 | — |
Q2 FY2025+0.00%
Report Date
May 9, 2025
EPS Beat/Miss
—
Price Before
$0.16
Price After
$0.16
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q3 FY2024+0.00%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Q2 FY2024+0.00%
Report Date
Jun 29, 2024
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Q2 FY2024+19.65%
Report Date
May 10, 2024
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.20
Q1 FY2024—
Report Date
Jan 4, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.17
Q3 FY2023—
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
—
Price After
$0.17
Q2 FY2023—
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
—
Price After
$0.17
Beat Rate0 / 8 quarters
Largest Move+19.65% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HOFBF ends December
Hofseth BioCare ASA (HOFBF) most recently reported earnings on May 9, 2025 for Q2 FY2025, posting EPS of $-0.01 (in line with the analyst consensus of —). The next HOFBF earnings date is expected around September 1, 2026.
Each quarter, investors track HOFBF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HOFBF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HOFBF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HOFBF earnings · 4 questionsHofseth BioCare ASA's next earnings report is expected around September 1, 2026. HOFBF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HOFBF historically reports after market close (AMC).
HOFBF earnings datewhen is HOFBF earningsHOFBF next earnings datewhen does HOFBF report earningsHOFBF earnings calendar
▸ Source: FMP · Hofseth BioCare ASA SEC filings · US GAAP · Hofseth BioCare ASA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026